Anish Bhatnagar has been the CEO of Soleno Therapeutics since February 2014. Before that, he climbed the ranks from President and COO, starting his journey with the company in 2006. His background is in medicine, having earned his medical degree...
Anish Bhatnagar has been the CEO of Soleno Therapeutics since February 2014. Before that, he climbed the ranks from President and COO, starting his journey with the company in 2006. His background is in medicine, having earned his medical degree at SMS Medical College in India. He has over 15 years of experience in the medical device and biopharmaceutical industries, working on biologics, drugs, and medical devices. He previously worked at companies like Coulter Pharmaceuticals and Titan Pharmaceuticals. His compensation reflects a significant increase over the years, earning over $1 million in total compensation recently, including a sizable bonus this past year. What's notable is his deep involvement in R&D and a commitment to driving company performance, aligning his interests closely with the shareholders.